Harvoni 33.75 mg/150 mg and 45 mg/200 mg coated granules in sachet
*Company:
Gilead Sciences LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 24 November 2022
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (November 2022).pdf
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 November 2022
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (November 2022).pdf
Reasons for updating
- Change to other sources of information section
Updated on 14 June 2022
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (May 2022).pdf
Reasons for updating
- Removal of Black Inverted Triangle
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 14 June 2022
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (May 2022).pdf
Reasons for updating
- Removal of Black Inverted Triangle
Updated on 09 September 2021
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (August 2021).pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 6.3 - Shelf life
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 09 September 2021
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (August 2021).pdf
Reasons for updating
- Change to section 2 - excipient warnings
Updated on 28 July 2021
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (July 2021).pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 28 July 2021
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (July 2021).pdf
Reasons for updating
- Change to other sources of information section
Updated on 04 June 2021
File name
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules SmPC (July 2020).pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 04 June 2021
File name
Harvoni 33.75 mg - 150 mg and 33.75 mg - 150 mg coated granules IE & XI PIL (May 2021).pdf
Reasons for updating
- New PIL for new product
Gilead Sciences Ltd
Address:
280 High Holborn, London, WC1V 7EE, UKMedical Information E-mail:
ukmed.info@gilead.comTelephone:
+44 (0)203 681 4500Medical Information Direct Line:
+353 214 825 999 , 08000 113 700 (UK)Customer Care direct line:
+44 (0)203 681 4681